SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-14-080982
Filing Date
2014-11-14
Accepted
2014-11-14 16:13:41
Documents
3
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a14-24505_110qa.htm 10-Q/A 92781
2 EX-31.1 a14-24505_1ex31d1.htm EX-31.1 4985
3 EX-31.2 a14-24505_1ex31d2.htm EX-31.2 4959
  Complete submission text file 0001104659-14-080982.txt   103747
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36167 | Film No.: 141224294
SIC: 2834 Pharmaceutical Preparations